Angiodynamics Inc (ANGO) — 10-Q Filings
All 10-Q filings from Angiodynamics Inc. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
AngioDynamics Narrows Loss on Strong Med Tech Sales Growth
— Oct 2, 2025 Risk: medium
AngioDynamics, Inc. (ANGO) reported a net loss of $10.903 million for the three months ended August 31, 2025, an improvement from the $12.798 million net loss i -
ANGIOGYNAMICS INC Files 10-Q for Feb 28, 2025
— Apr 2, 2025 Risk: medium
ANGIOGYNAMICS INC filed a 10-Q for the period ending February 28, 2025. The filing details financial information for the company, which operates in the surgical -
ANGIODYNAMICS INC. Files Q2 2025 10-Q Report
— Jan 8, 2025 Risk: medium
ANGIODYNAMICS INC. filed its 10-Q for the period ending November 30, 2024, reporting on its financial performance. The company, based in Latham, NY, operates in -
ANGIODYNAMICS INC. Files Q2 2024 10-Q Report
— Oct 3, 2024 Risk: medium
ANGIODYNAMICS INC. filed its 10-Q report for the period ending August 31, 2024. The company, based in Latham, NY, operates in the surgical and medical instrumen -
ANGIODYNAMICS INC Files 10-Q for Period Ending 2024-02-29
— Apr 9, 2024 Risk: low
ANGIODYNAMICS INC (ANGO) filed a Quarterly Report (10-Q) with the SEC on April 9, 2024. ANGIODYNAMICS INC filed a 10-Q report on 2024-04-09 for the period endin -
ANGIODYNAMICS INC Files 10-Q for Period Ending 2023-11-30
— Jan 8, 2024 Risk: low
ANGIODYNAMICS INC (ANGO) filed a Quarterly Report (10-Q) with the SEC on January 8, 2024. ANGIODYNAMICS INC filed a 10-Q report for the period ending November 3
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX